Purpose of this guideline The purpose of this guideline is to provide evidence-based guidance about the identification, assessment, and management of suicide and NSSI in children and adolescents (0-19 years) to ensure optimal and consistent care.
Read more
Getting treatment for an eating disorder can be a daunting process given that most people know little about eating disorders and effective treatments.
Read more
After over six months of consultation with the eating disorders community and wider health sector, NEDC has published a consultation report which outlines our findings.
Read more
Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more
